This investigation provides a novel finding that Fluoxetine may ameliorate early brain injury after subarachnoid hemorrhage through anti-apoptotic effects and Notch1/ASK1/p38 MAPK signaling pathway. The gene discussed is MAP3K5; the disease is subarachnoid hemorrhage.